Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
BIOMEA FUSION INC
About BMEA
Biomea Fusion, Inc. is a clinical-stage diabetes and obesity medicines company focused on the discovery and development of oral covalent small molecules to improve the lives of patients with diabetes, obesity, and metabolic diseases. A covalent small molecule is a synthetic compound that forms a permanent bond to its target protein. The Company has built its proprietary FUSION System discovery platform to advance a pipeline of small molecule product candidates. Its lead clinical program’s drug candidate, icovamenib, is being developed as an orally bioavailable, and selective covalent inhibitor of menin in two clinical and multiple preclinical studies, investigating icovamenib’s potential in type 1 and type 2 diabetes, as well as its impact in obesity. Its second product candidate BMF-650, is an investigational, oral small-molecule glucagon-like peptide-1 receptor agonists (GLP-1 RA), for the treatment of diabetes and obesity.
Find out what a historical investment in BIOMEA FUSION INC would be worth today using our BMEA stock calculator.
Market Capitalisation
$97.60M
Price-earnings ratio
-
Dividend yield
0.00%
Volume
1.91M
High today
$1.45
Low today
$1.32
Open price
$1.42
52-week high
$3.08
52-week low
$0.87
Ready to start your investing journey with Stake?
Open an accountHow do I buy BMEA shares in Australia?
Buying BMEA shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in BIOMEA FUSION INC in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in BMEA
What is the ticker symbol of BIOMEA FUSION INC?
The ticker symbol for BIOMEA FUSION INC is BMEA.
How much is one share of BMEA?
One share of BMEA is valued at $1.34 as of 16 May 2026.
What is the market capitalisation of BIOMEA FUSION INC BMEA?
As of 16 May 2026 BIOMEA FUSION INC has a market cap of $97.60M.
What is the 52-week high for BIOMEA FUSION INC stock?
The BIOMEA FUSION INC 52-week high stock price is $3.08.
What is the 52-week low for BIOMEA FUSION INC stock?
The BIOMEA FUSION INC 52-week low stock price is $0.87.
Can I buy BMEA shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy BMEA shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in BMEA on Stake
- Buy BMEA from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of BMEA from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
BMEA related stocks